Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Denton council approves incentives and tax abatement for Novartis Gene Therapies expansion

Denton City Council · December 16, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Denton City Council unanimously approved an incentive package and a Chapter 312 tax abatement for Novartis Gene Therapies to redevelop a 50,000 sq. ft. site in Denton, a project staff estimates will invest about $280 million and create roughly 150–175 jobs.

The Denton City Council on Dec. 16 approved economic-development incentives and a tax abatement for Novartis Gene Therapies, clearing the way for the pharmaceutical company to redevelop a mothballed 50,000-square-foot facility at 2101 Shady Oaks Drive.

Staff presented a multi-phase plan in which Novartis would remove hazardous materials, complete environmental remediation and renovate existing buildings, followed by upgrades to enable specialized manufacturing. Economic development…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans